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Cdc14 is an essential phosphatase in yeast but its role in the mammalian cell cycle remains obscure. We
report here that Cdc14b-knockout cells display unscheduled induction of multiple cell cycle regulators
resulting in early entry intoDNA replication andmitosis fromquiescence. Cdc14b dephosphorylates Ser5 at
the C-terminal domain (CTD) of RNApolymerase II, amajor substrate of cyclin-dependent kinases. Lack of
Cdc14b results in increased CTD-Ser5 phosphorylation, epigenetic modifications that mark active
chromatin, and transcriptional induction of cell cycle regulators. These data suggest a function for
mammalian Cdc14 phosphatases in the control of transcription during the cell cycle.
P
rogression throughout the cell cycle is known to be tightly regulated by cyclin-dependent kinases (Cdks),
whose enzymatic activity promotes DNA replication and mitosis1. The relevance of the counteracting
phosphatases has been less studied. In Saccharomyces cerevisiae, the protein phosphatase Cdc14 is essential
for the inactivation ofmitotic Cdks andmitotic exit by dephosphorylatingmanyCdk substrates2,3. The subcellular
localization of ScCdc14 is regulated initially by the FEAR network which functions in early anaphase and
subsequently by theMitotic Exit Network (MEN)which is active in late anaphase. In Schizosaccharomyces pombe,
the localization of the Cdc14-like phosphatase Clp1/Flp1, which also antagonizes mitotic Cdk activity, is regu-
lated by the septation-initiation network (SIN), a signaling pathway homologous to the MEN.
Two Cdc14 orthologs, Cdc14a and Cdc14b, exist in all mammals. These proteins are able to rescue the
phenotype of Flp1-deficient yeast strains and Cdc14b, in particular, is able to fulfill all essential functions of
ScCdc14 suggesting some functional conservation4,5. However, the dephosphorylation of Cdk phosphosites
seems to rely mostly on PP2A-B55 complexes during mammalian mitotic exit6,7 and the relevance of Cdc14
phosphatases is not clear. Cdc14a specifically regulates centrosome function and prevents premature Cdk1
activation8 whereas Cdc14b has been proposed to play multiple functions during the cell cycle9. Cdc14b is able
to induce malignant transformation in vitro although this activity has no clear links to direct cell cycle regu-
lation10. Recent knockout studies in established cell lines have shown not obviousmitotic defects in the absence of
these proteins, although mammalian Cdc14 phosphatases have been suggested to be required for efficient DNA
repair11,12. Genetic ablation of Cdc14b exon 2 in the mouse resulted in proliferative defects and increased
senescence both in vitro and in vivo13. In thismanuscript, we report that lack ofmouse Cdc14b results in increased
transcription of cell cycle-specific genes. This function correlates with the ability of Cdc14b of removing phos-
phate residues from Ser5 of the C-terminal domain (CTD) of RNA polymerase II, a site known to modulate
several epigenetic marks required for gene transcription.
Results
Cell cycle alterations in Cdc14b-deficient cells. We have generated a new Cdc14b null allele in the mouse by
excising exons 8-9 which encodemost of the phosphatase catalytic domain. As reported recently13,Cdc14b(2/2)
mice are viable although develop some pathologies that will be described elsewhere. Cdc14b(2/2) primary
mouse embryonic fibroblasts (MEFs) grew well in culture during the first passages and do not show
differences in cell proliferation in asynchronous cultures (Fig. 1a–c). The duration of mitosis was normal and
these cells do not show any defect during mitotic exit in the absence (Fig. 1a) or presence (Fig. 1d) of mitotic
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poisons. Similarly, Cdc14b-deficient MEFs displayed normal levels
of cH2AX, a marker of replicative stress or DNA damage, in
untreated cultures at different passages (Fig. 1e) or upon c-
irradiation (10 Gy; Fig. 1f). Moreover, these mutant cells did not
display obvious deficiencies in checkpoint function or DNA repair
since cH2AX signal decay occurred with normal kinetics in the
absence of Cdc14b at passage 3 (Fig. 1f). Whether these cells may
have additional deficiencies in DNA damage checkpoint of DNA
Figure 1 | Normal cell cycle progression in asynchronous Cdc14b-null cells. (a) Primary MEFs were transduced with lentiviruses expressing Histone
H2B-GFP and cells were recorded by videomicroscopy. Time 0 indicates mitotic entry. No differences are found in the duration ofmitosis in wild-type or
Cdc14b-null cells. (b) Growth curve of Cdc14b-null and control primary MEFs during 6 days. (c) Percentage of mitotic cells in these asynchronous
cultures. (d) Mitotic exit kinetics in Cdc14b-null (N584) and control (N567) cells in the presence of nocodazole. Cells were arrested in prometaphase
with nocodazole and the percentage of mitotic cells, as observed by videomicroscopy, is scored showing no differences between these two genotypes
duringmitotic slippage. All these graphs show representative results from at least three separate experiments. (e) Immunofluorescence staining of passage
7 (P7) primary MEFs and quantification of the percentage of cH2AX positive cells in primary MEFs at passages 3, 5 and 7. (f) Immunofluorescence
staining of passage 3 (P3) primary MEFs after 10 Gy of c2irradiation. Quantification of cH2AX-positive cells and the average cH2AX intensity per cell
shows no significant differences between wild-type and Cdc14b-null cultures. All these graphs show results from three separate experiments.
www.nature.com/scientificreports
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repair under different culture conditions (senescence) or in different
genetic backgrounds remains to be explored.
Despite the lack of obvious defects in asynchronous cultures, a
detailed analysis of mitotic entry by videomicroscopy revealed that
Cdc14b(2/2) MEFs entered earlier in mitosis (24.59 6 3.07 h after
serum stimulation vs. 28.90 6 3.49 h in wild-type cells; p,0.003;
Fig. 2a,b) when released from quiescence. We initially checked the
expression of several mitotic regulators such as cyclin B1, Cdk1 or
Aurora B and found a general upregulation of these proteins during
early time points. This correlated with earlier phosphorylation of
histone H3 (an Aurora-B substrate) or Cdk substrates (Fig. 2c).
These data could be in agreement with a role for Cdc14 phosphatases
in the control of Cdk1 activation during G2 as suggested prev-
iously8,14,15. However, this putative function does not explain the
upregulation of some of these proteins at early time points (20–
23 h) at which most wild-type cells have not completed S phase
(Fig. 3a). Thus, we wondered whether a similar alteration in express-
ion levels was found in G1/S regulators. Both cyclin E and cyclin A,
but not cyclin D2, were upregulated in Cdc14b(2/2) cells, and these
alterations correlated with increased levels in the phosphorylation of
the retinoblastoma protein (pRb), a Cdk substrate whose phosphor-
ylation induces the G1/S transition (Fig. 3b). Indeed, Cdc14b(2/2)
cells entered S-phase with a faster kinetics as determined by the
incorporation of nucleotide analogs (Fig. 3a). Thus, although we
cannot discard a direct function for Cdc14b in Cdk1 activation, these
data suggest a specific deregulation of the levels of G1/S regulators in
the absence of Cdc14b.
Cdc14 phosphatases modulate phosphorylation of RNA
polymerase II. Transcriptional control during the cell cycle is
mediated by so-called ‘‘cell cycle’’ and well as ‘‘transcriptional’’
Cdks1. Whereas the first group (Cdk1-4,6) phosphorylates pRb
to inactivate its repressor functions, the second group (Cdk7-9)
phosphorylates the C-terminal domain (CTD) of the largest
subunit (Rpb1) of RNA polymerase II (RNAPII) thus activating
the transcriptional machinery. Since Cdc14 phosphatases have
preference for Cdk substrates we then tested whether these two
major Cdk substrates, pRb and RNAPII, are dephosphorylated by
Cdc14 mammalian phosphatases. As shown in Fig. 4a, Cdc14a, but
not Cdc14b, was able to efficiently remove phosphates added by
Cdk1-cyclin B1 complexes on pRb. However, both Cdc14a and
Cdc14b were able to dephosphorylate the RNAPII-CTD and,
interestingly, whereas Cdc14a was able to decrease the phosphor-
signal in Ser2 and Ser5, Cdc14b displayed certain preference for Ser5
(Fig. 4a).
To further test the molecular interactions between Cdc14b and
RNAPII we then analyzed whether these proteins can be found as a
complex in mammalian cells. Since current available antibodies do
not detect endogenous Cdc14b proteins, we instead used a Cdc14b-
GFP fusion protein. As observed in Fig. 4b, the endogenous Rpb1was
detected in Cdc14B-GFP immunoprecipitates, but not in lysates
from cells expressing GFP alone. In addition, immunoprecipitation
of the endogenous Rpb1 was able to pull down the Cdc14b-GFP
fusion protein but not GFP alone, suggesting specific interaction
between Cdc14b and RNAPII complexes.
Transcriptional activation of cell cycle genes in Cdc14b-null cells.
RNAPII regulation is crucial for controlling the status of gene
expression and has significant consequences for cell response path-
ways. The phosphorylation of the CTDmodulates the recruitment of
Figure 2 | Early mitotic entry in synchronous Cdc14b-deficient cells. (a) Primary MEFs were serum starved for 72 h and forced to enter into cell cycle
after stimulation with 20% fetal bovine serum (FBS). Micrographs show an earlier mitotic entry in Cdc14b(2/2) than in Cdc14b(1/1) cells. The
percentage of mitotic cells was scored after immunofluorescence with DAPI and phospho-histone H3 at different time points after serum stimulation.
These graphs show representative results from at least three separate experiments. (b) Cdc14b(2/2) and Cdc14b(1/1) MEFs expressing H2B-GFP were
recorded by videomicroscopy during 35 h after serum stimulation. Cdc14b(2/2) cells enter earlier in mitosis but no differences were found in the
duration of mitosis (N5 70–90 cells per genotype). (c) Immunodetection of the indicated mitotic proteins in total lysates from Cdc14b(1/1) and
Cdc14b(2/2) MEFs at the indicated time-points after serum stimulation. These blots are representative from at least three different experiments.
www.nature.com/scientificreports
SCIENTIFIC REPORTS | 1 : 189 | DOI: 10.1038/srep00189 3
chromatinmodification enzymes. Thus, phosphorylation of RNAPII
CTDat Ser5 promotesH3 andH4 acetylation at active promoters16–18
and is crucial for high levels of methylation of histone H3 lysine 4
(H3K4) at active promoters16,19,20. In agreement with the ability of
Cdc14b to dephosphorylate RNAPII, Cdc14b-null cells displayed
increased CTD-Ser5 and H3K4me3 signals, as well as increased
acetylation of histones H3 and H4 (Fig. 4c,d). These marks of
active chromatin were also increased during the early phases of the
cell cycle (0–10 h after cell cycle entry from quiescence; Fig. 4e) in
correlation with decreased levels of specific repression marks such as
H3K9me3, a binding site for heterochromatin protein 1 (HP1) which
blocks access by the transcription factors and polymerases required
for gene transcription.
To further analyze the consequences of the genetic ablation of
Cdc14b in transcription, we analyzed the expression profile in
Cdc14b-deficient cells. Cdc14b-null cells displayed a significant (p
, 0.01) induction of genes involved in three molecular routes: G1
pathway (FDR5 0.071), cell cycle regulation (FDR5 0.013), and the
ALK pathway (FDR50.016), which triggers cell cycle progression by
transducing several mitogenic signals (Fig. 5a and Table 1). As an
example, Cdc14b-null cells displayed increased transcript levels of A-
type and B-type cyclins (Fig. 5b), in agreement with the overexpres-
sion of the corresponding proteins (Figs. 2 and 3). In addition,
ectopic expression of Cdc14b in normal fibroblasts results in a sig-
nificant repression of A- and B-type cyclins. This effect is not
observed upon ectopic expression of a phosphatase-dead form of
Cdc14b (Fig. 5b), in agreement with a catalytic function of Cdc14b
in the transcriptional repression of cell cycle regulators.
Discussion
Whereas the relevance of yeast Cdc14 during mitotic exit has been
well established2, other phosphatases such as PP1 or PP2A/B55 seem
to drive mitotic exit in mammals6,7,21. Mammalian Cdc14 phospha-
tases are able to dephosphorylate several Cdk substrates including
Sirt2, Cdc25, Erk3, Skp2 or Cdh1, among others [reviewed in Ref.9].
Yet, their relevance during the cell cycle remains obscure and loss-of-
function studies have shown that individual inactivation of mam-
malian Cdc14a or Cdc14b does not compromise cell proliferation.
By generating Cdc14b-knockout primaryMEFs, we have observed
a role for Cdc14b in the entry into the cell cycle from quiescence.
Cdc14b-null MEFs display increased levels of multiple cell cycle
regulators, such as A- or B-type cyclins, as well as Cdk1, in correla-
tion with earlier entry into S-phase and mitosis. The alteration in the
levels of these proteins could be due to an effect of Cdc14b in the
degradation machinery. In fact, Cdc14 proteins may dephosphory-
late the Anaphase-promoting complex (APC/C) cofactor Cdh1, thus
promoting the activation of APC/C-Cdh1 complexes and the ubi-
quitination and subsequent degradation of several cell cycle regula-
tors22,23. The absence of Cdc14b could therefore result in lack of
activation of Cdh1 and defective degradation of several cell cycle
regulators. Thismechanism, however, does not explain the alteration
in the levels of Cdk1 (Fig. 2c) or Cyclin E (Fig. 3b) which are not
APC/C targets. On the other hand, Cdh1-deficient MEFs display a
distinct phenotype including defective progression through S-phase
and do not display the earlier entry into mitosis observed in Cdc14-
deficient cells24. These results suggest that Cdc14bmay alsomodulate
cell cycle progression by regulating transcription. Although pRb is a
Figure 3 | Earlier entry into S-phase in Cdc14b-null cells. (a) MEFs were pulsed with EdU after serum stimulation and the percentage of EdU-positive
cells was scored at different time-points. (b) Immunodetection of the indicated cell-cycle proteins in total lysates from Cdc14b(1/1) and Cdc14b(2/2)
MEFs at the indicated time-points after serum stimulation. These results show representative data from at least three separate experiments with different
MEFs.
www.nature.com/scientificreports
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major transcriptional target of Cdks during the cell cycle25, this pro-
tein does not seem to be efficiently dephosphorylated by Cdc14b, at
least in vitro (Fig. 4a).
RNA polymerase II (RNAPII), which transcribes all protein-
coding genes and many non-coding RNAs, is another well-known
substrate of Cdks. Rpb1, the largest subunit of RNAPII, contains an
unusual CTD that comprises 52 repeats of the heptapetide consensus
sequence YSPTSPS. Post-translational modifications, such as phos-
phorylation, glycosylation and cis-trans isomerization, at any of these
residues generate a complex regulatory code that dictates the func-
tional state of the polymerase20,26. The CTD repeat contains two pro-
line-directed serines (Ser2 and Ser5) that are major targets of
co-called transcriptional Cdks (Cdk7-9)1. However, the CTD is not
only phosphorylated by transcriptional Cdks since cell-cycle Cdks
such as Cdk1 or Cdk2 may also phosphorylate Ser2 and Ser5 of
the CTD [reviewed in Refs.16,27]. This dual role is likely to promote
the necessary link between cell cycle progression and transcription1
although the molecular details have not been explored. Both Cdc14a
and Cdc14b are able to dephosphorylate Cdk-dependent phosphosites
in the RNAPII CTD (Fig. 4a). Whereas Cdc14a is active both in Ser2
and Ser5, Cdc14b seems to preferentially dephosphorylate Ser5.
Similarly, Ser5 is preferentially phosphorylated by Cdk7-9, as well
as mitogen-activated protein kinases (ERK), whereas Cdk1-2 can
modify both Ser2 and Ser5 with similar selectivity27. The phosphor-
ylation of these two sites has distinct implications during mRNA
processing, and different repeats in the CTD may serve different
functions, adding a further level of complexity to the CTD code.
Phosphorylation of RNAPII also mediates the recruitment of chro-
matin remodeling enzymes. For instance, phosphorylation of Ser5
contributes to the association of methyltransferases onto the 59-
portion of actively transcribed genes shortly after initiation, thereby
enhancing histone H3 K4 trimethylation (H3K4me3). Lack of
Cdc14b results in increased phopho-Ser5 signal as well as in-
creased H3K4me3, suggesting that Cdc14b deficiency may enhance
RNAPII-mediated transcription. How this deregulation affects to
specific genes is not clear. Cell division is normal in asynchronous
Cdc14b-null cultures and the deregulation of cell cycle genes is only
obvious during the re-entry into the cell cycle from quiescence. Thus,
Figure 4 | Cdc14 proteins dephosphorylate RNA polymerase II and repress transcription. (a) The C-terminal domain (CTD) fragment of RNA
polymerase II and pRb (amino acids 773–928) were used as substrates of Cdk1-cyclin B complexes in the presence of 32P-ATP or non-radiactive
ATP and then incubated with GST-Cdc14a, GST-Cdc14b, phosphatase-dead mutants or GST alone. Samples were resolved by SDS-PAGE and detected
by autoradiography or immunoblot with antibodies against Rpb1 or specific for phospho-Ser2 (P-S2) and phospho-Ser5 (P-S5) forms of the CTD.
(b) Immunoblots of cell lysates from 293 cells expressing Cdc14b-GFP or GFP alone, before (INPUT) or after immunoprecipitation (IP) with either GFP
or Rpb1 antibodies. The endogenous Rpb1 was detected using specific antibodies whereas exogenous Cdc14b-GFP (14bGFP) was detected using specific
antibodies against GFP (* indicates non-specific bands). (c) Immunodetection of phospho-Ser2 (P-S2) and phospho-Ser5 (P-S5) forms of the CTD in
asynchronous (AS)MEFs or in cells serum-deprived for 24 or 48 h. The relative levels of these marks versus asynchronous wild-type cells are indicated in
the histograms. (d) Immunodetection of phospho-Ser5 CTD and the indicated epigenetic marks during serum starvation in wild-type or Cdc14b-null
cells. (e) Immunodetection of the indicated epigenetic marks during cell cycle entry after stimulation of quiescent cells (serum-starved for 48 h) with
serum. Samples were analyzed 0, 10, 18 and 26 h. after stimulation with serum. GADPH was used as a loading control in all these immunodetection
studies.
www.nature.com/scientificreports
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Cdc14b could participate in the dephosphorylation of RNAPII
during quiescence or during the early phases of the cell cycle.
Since Cdc14b is localized at the nucleolus, this may specifically affect
to nucleolus-associated heterochromatic regions, although these hy-
pothesis deserve further investigation.
Altogether, our results suggest that mammalian Cdc14b depho-
sphorylates RNAPII-CTD Ser5, a modification known to contri-
bute to the transcriptional activation of chromatin by increasing
H3K4me3 and acetylation of histones H3 and H4. Lack of Cdc14b
results in increased phospho-Ser5 levels, in correlation with the pres-
ence of epigenetic modifications, such as H3K4me3 or acetylated H3
and H4, that mark active chromatin. These alterations may contrib-
ute to the transcriptional induction of specific cell cycle regulators as
detected by gene expression profiling. Since yeast Cdc14 also regu-
lates transcription throughout the control of RNA polymerase II
(L. Arago´n, personal communication), these data indicate that the
repression of cell cycle machinery is a critical, conserved function of
Cdc14 phosphatases to regulate cell division.
Methods
Generation of Cdc14-null mice. The murine Cdc14b locus was modified by flanking
exons 8 and 9 with loxP sequences using a routine targeting strategy24. Two out of 559
ES cell clones analyzed underwent homologous recombination and were aggregated
to generate quimeras. Expression of Cre recombinase24 resulted in the excision of
exons 8–9 creating the null allele [Cdc14b(2/2)]. Further details on the targeting
strategy and genotyping protocols are available upon request. Animal procedures
were approved by the corresponding Ethics Committee of Animal Experimentation
in our institution.
Cell culture and immunofluorescence. Primary MEFs were prepared from E14.5
embryos essentially as described previously24. For cell cycle re-entry synchronization,
early passage primaryMEFs were starved in DMEM1 0.1% fetal bovine serum (FBS)
for 72 hours and re-stimulated with 20% FBS. These cultures were treated with
nocodazole (100 ng/ml; Sigma) 20 h after re-stimulation. EdU incorporation was
assayed according to the manufacturer’s protocol (ClickiT EdU assay kit; Molecular
Probes, Invitrogen). For videomicroscopy, H2B-GFP expressing cells were recorded
using a Deltavision Apparatus (Applied Precision) using 5 min frames during 35 hr.
To induce DNA damage, primary MEFs at passage 3 where synchronized at G0 by
serum starvation and 20 h after serum stimulation they were c-irradiated (10 Gy) for
5 minutes. Nocodazole (100 ng/ml; Sigma) was added immediately to prevent
mitotic exit. For immunostaining, cells were cultured on coverslips, fixed in 4%
paraformaldehyde (PFA), permeabilized in 0.5% Triton X-100, and blocked with PBS
containing 10% donor calf serum. Cells were then incubated with primary antibodies
(cH2AX, Upstate biotechnology) for 2 h at room temperature and with fluor-
conjugated secondary antibodies (Alexa 594) for 45 min at room temperature.
Finally, cells were counterstained with DAPI (49,6-diamidino-2-phenylindole) to
visualize DNA.
Biochemical analysis and phosphatase assays. For Western blotting, cells were
harvested and lysed in RIPA buffer, and 50 mg of total protein was separated by
SDS-PAGE and probed with antibodies against phosphoSer-CDKs substrates (Cell
Signaling Technology), cyclin B1 (Chemicon International), phospho-Histone H3
(Millipore), Cdk1 (Santa Cruz), Aurora B (Abcam), Cyclin A2 (Santa Cruz), cyclin
D2 (Santa Cruz), Cyclin E (Abcam), p21Cip1 (Santa Cruz), p27Kip1,(BD Transduction
Laboratories), pRb P-S780 and pRb P-S807/810 (Cell signalling), H3K9ac (Abcam),
H3K9me3 (Abcam), H3ac, H4ac, H3K4me3 (Upstate) and a-Actin (Sigma). For in
vitro phosphatase assays, a pRb fragment (6xHis-hRb, aa773-928; Upstate) and the
C-terminal domain (CTD) of human Rpb1 (purified from bacteria as a GST-CTD
fusion protein using the pGEX-2TK vector) were used as substrates. These peptides
were incubated with 2U of Cdk1-Cyclin B1 (New England Biolabs) in kinase buffer
(50 mMTris, pH 7.5, 10 mMMgCl2, 1 mMEGTA, 1 mMDTT and 50 mMATP) in
the presence of 0.15 mCi of c(32P)ATP for 30 min at 30uC. Samples were then washed
three times with 1 ml of phosphatase buffer (20 mM Tris, pH 8.3; 150 mM NaCl;
2 mMEDTA; 0.1% Triton X-100; 5 mMDTT) and incubated for 45 minutes at 30uC
with GST-Cdc14a, GST-Cdc14b or their corresponding inactive forms, Cdc14a
C278S and Cdc14b C314S, in the above phosphatase buffer. Approximately the same
catalytic activity (as measured on the pNPP) was used for Cdc14a and Cdc14b.
Reactions were stopped by the addition of loading buffer and boiling for 5 min at
95uC. Proteins were resolved by SDS-PAGE and visualized by Comassie staining and
autoradiography or detectedwith specific antibodies: CTDphospho-Ser5 (Millipore),
CTD phospho-Ser2 (Abcam), anti-RNA polymerase II (Millipore). For
immunoprecipitation studies, cell lysates (1000 mg of protein) were incubated for 2 h
at 4uC in a total volume of 300 ml with either 25 ml of mouse monoclonal anti-GFP
(GFP; Roche) or 10 ml of mouse monoclonal anti-RNA pol II (Abcam clone AB5408)
followed by incubation of protein G beads (Amersham) for an additional hour.
Immunoprecipitates were collected by centrifugation, washed four times with a lysis
buffer containing NaCl 0.5 M, and subjected to SDS-PAGE electrophoresis and
immunoblot analysis.
Figure 5 | Altered transcriptional profiles in Cdc14b-deficient cells. (a) Transcriptional alteration of cell cycle regulators in Cdc14b-null cells (blue side
in the red-blue bar; FDR50.013). Gene annotations were retrieved from Biocarta. (b) Relative levels of the indicated transcripts in Cdc14b-null cells or in
wild-type cells overexpressing Cdc14b or the phosphatase-dead (PD) form of Cdc14b. Fold induction is in red whereas fold repression is in blue. Cdc14b-
null cells were normalized versus the levels in wild-type cells whereas overexpression of Cdc14b or Cdc14b PDwas normalized versus cells transfectedwith
the empty vector.
Table 1 | Significant deregulation of Biocarta pathways in asynchronous Cdc14-null MEFs
Biocarta pathways Adjusted pvalue (FDR) Genes
Alk Pathway 0.016 Gsk3B, Tcf1, Bmp7, Atf2, Apc, Tgfbr1, Bmp10, Nkx2-5, Chrd, Tgfb1, Gata4, Acvr1, Mef2C,
Dvl1, Axin1, Bmpr2, Tgfbr2, Fzd1, Bmpr1a, Tgfbr3, Bmp5, Wnt1, Rfc1, Map3K7, Bmp2, Nppb,
Tgfb2, Nppa, Nog, Tgfb3, Bmp4.
G1 pathway 0.071 Gsk3B, Tp53, Cdkn1B, E2F1, Atm, Ccna1, Cdk4, Atr, Cdk6, Dhfr, Tgfb1, Abl1, Cdk2, Tfdp1, Rb1,
Cdc25a, Skp2, Ccne1, Hdac1, Tgfb2, Cdkn1a, Cdkn2B, Cdkn2a, Tgfb3, Ccnd1.
Cell Cycle 0.135 Cdkn1B, Rbl1, Ccnb1, Ccnh, E2F1, Ccna1, Cdk4, Cdkn2D, Cdk6, Cdk2, Tfdp1, Cdkn2C, Rb1,
Cdc25a, Ccne1, Cdk7, Cdkn1a, Ccnd3, Ccnd2, Cdkn2B, Cdkn2a, Ccnd1.
www.nature.com/scientificreports
SCIENTIFIC REPORTS | 1 : 189 | DOI: 10.1038/srep00189 6
Transcriptional profiling. Total RNA was prepared from cells using TRIzol reagent
(Invitrogen). Gene expression arrays were purchased from Agilent and processed
according to the manufacturer’s recommendation. Significantly deregulated mRNAs
were computed using the TM4 package (http://www.tm4.org) and the Limma
package fromBioconductor (http://www.bioconductor.org). Three different clones of
cells overexpressing the indicated vectors or lacking Cdc14b were compared to the
corresponding controls. Gene Set Enrichment Analysis (GSEA) was carried out using
limmamoderated t statistic for gene ranking28. The effect of overexpression of Cdc14
or the phosphatase-dead (PD) form of Cdc14b was analyzed as reported previously10.
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